Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

RegulatoryNegative

AI Analysis

Summary

Cellyan Biotechnology received a notification from Nasdaq's Listing Qualifications Department granting an additional 180-day grace period until January 11, 2027 to regain compliance with the minimum $1.00 closing bid price requirement. The company must maintain a closing bid price of at least $1.00 for ten consecutive business days to avoid delisting.

Outcome Details

Granted additional 180-day compliance grace period to regain minimum $1.00 closing bid price requirement

Importance:4/10

Sentiment:

-0.60

Nasdaq listing complianceminimum bid price requirementregulatorygrace period

Related Companies

$HKPD

Read the original article

Published by GlobeNewswire Pharma on July 16, 2026 8:30 PM

Read Original